RAPT Therapeutics to be Acquired by GSK for $58 per Share Amid Shareholder Investigation
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 20 2026
0mins
Source: Globenewswire
- Acquisition Overview: RAPT Therapeutics is set to be acquired by GlaxoSmithKline for $58 per share, representing an estimated aggregate equity value of $2.2 billion, prompting an investigation into whether the board breached its fiduciary duties, potentially impacting shareholder rights.
- Calavo Acquisition Details: Calavo Growers will be acquired by Mission Produce, with shareholders receiving $27 per share, including $14.85 in cash and 0.9790 shares of Mission, valuing the enterprise at approximately $430 million, while an investigation questions the fairness of the board's process.
- Penumbra Acquisition Status: Penumbra will be acquired by Boston Scientific in a deal valued at $374 per share, reflecting an enterprise value of about $14.5 billion, with investigations focusing on whether the board failed to ensure fair treatment for shareholders.
- FONAR Acquisition Investigation: FONAR Corporation will be acquired for $19 per share in an all-cash transaction, with investigations examining whether the board neglected its fiduciary duties during the acquisition process, which could affect shareholder interests.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like CVGW with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on CVGW
About CVGW
Calavo Growers, Inc. is a provider of value-added fresh food in the avocado industry. The Company is engaged in marketing and distributing avocados and prepared avocados to retail grocery, foodservice, club stores, mass merchandisers, food distributors and wholesalers on a worldwide basis. It procures avocados from California, Mexico and other growing regions around the world. Through its various operating facilities, it sorts, packs, and/or ripens avocados, tomatoes and/or Hawaiian grown papayas, and processes and packages guacamole. It operates in two business segments: Grown and Prepared. Its Grown segment consists of fresh avocados, tomatoes and papayas. Its Prepared segment comprises all its guacamole products sold at retail and food service as well as avocado pulp sold to foodservice. Its products are sold under the Calavo family of branded labels, as well as private labels. It distributes its products both domestically and internationally.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Halper Sadeh Investigates Allegiant Travel's Merger with Sun Country Airlines
- Merger Investigation: Halper Sadeh LLC is investigating Allegiant Travel Company's merger with Sun Country Airlines, where Allegiant shareholders are expected to own approximately 67% of the combined entity post-transaction, potentially impacting shareholder rights.
- Cash and Stock Deal: Sun Country Airlines is being sold to Allegiant for 0.1557 shares of Allegiant common stock and $4.10 in cash per share, raising concerns among shareholders regarding the fairness of the transaction structure.
- Calavo and Mission Merger: Calavo Growers, Inc. is being sold to Mission Produce, Inc. for $14.85 in cash and 0.9790 shares of Mission stock, with Mission shareholders expected to own about 80.3% of the combined company post-transaction, which may affect shareholder decision-making.
- Legal Rights Protection: Halper Sadeh LLC offers legal services on a contingency fee basis, encouraging shareholders to reach out to discuss their legal rights and options, demonstrating a commitment to protecting shareholder interests.

Continue Reading
United Breweries Co. Achieves 2.8% Dividend Yield with 11% Stock Price Increase
- Dividend Yield Increase: United Breweries Co. (CCU) currently boasts a 2.8% dividend yield with a payout ratio of 58.9%, indicating sustainability and attractiveness in the beverage market, which has garnered investor interest.
- Stock Price Uptrend: CCU's stock price has risen over 11% at the start of the new year, forming a Golden Cross as the 50-day simple moving average crossed above the 200-day moving average, signaling a potential new bull market.
- Technical Indicator Confirmation: The MACD indicator shows a bullish crossover, indicating accumulating upward momentum, while the Relative Strength Index (RSI) has dipped below 70, suggesting potential for further price increases.
- International Diversification Investment: Cresud SACIF (CRESY), as a Latin American commodities producer, offers a dividend yield exceeding 5% and provides a solid investment diversification opportunity during geopolitical tensions, showcasing robust performance in agriculture and real estate.

Continue Reading








